Heidelberg Pharma AG (ETR:HPHA)

Germany · Delayed Price · Currency is EUR

2.080

-0.070 (-3.26%)

Oct 26, 2026, 5:35 PM CET

Heidelberg Pharma AG Financials Overview

Financials in millions EUR. Fiscal year is December - November.

Millions EUR. Fiscal year is Dec - Nov.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 31, 2026	Nov '25 Nov 30, 2025	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021
Revenue	9.32	1.46	6.85	9.86	18.51	2.03
Revenue Growth	206.78%	-78.72%	-30.53%	-46.75%	810.30%	-76.53%
Gross Profit	7.54	1.19	5.07	6.61	13.83	-2.68
Operating Income	-32.83	-48.93	-21.83	-27.55	-18.29	-25.84
Net Income	-29.9	-42.28	-19.38	-20.35	-19.7	-26.14
Earnings Per Share	-0.66	-0.91	-0.42	-0.44	-0.53	-0.80
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '25 Nov 30, 2025	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021
Germany	0.01	0.03	0.06	0.55	0.48
USA	0.29	2.14	4.67	8.98	1.12
China	1.17	4.67	4.74	8.2	-
Total	1.46	6.85	9.86	18.51	1.75

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 31, 2026	Nov '25 Nov 30, 2025	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021
Cash & Investments	19.84	14.98	29.42	43.44	81.33	6.14
Total Debt	0.3	0.11	0.16	5.83	15.98	10.63
Net Cash (Debt)	19.54	14.86	29.26	37.61	65.35	-4.49
Net Cash Growth	-14.06%	-49.20%	-22.20%	-42.45%	-	-
Net Cash Per Share	0.43	0.32	0.63	0.81	1.76	-0.14

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 31, 2026	Nov '25 Nov 30, 2025	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021
Operating Cash Flow	-19.14	-31.6	-29.59	-33.67	-8.86	-26.61
Capital Expenditures	0.03	-0.13	-0.46	-0.94	-0.58	-1.24
Free Cash Flow	-19.11	-31.73	-30.04	-34.61	-9.45	-27.85
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 31, 2026	Nov '25 Nov 30, 2025	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021
Gross Margin	80.93%	81.31%	74.00%	67.01%	74.72%	-131.69%
Operating Margin	-352.32%	-3357.60%	-318.71%	-279.41%	-98.81%	-1270.65%
Pretax Margin	-305.08%	-2829.08%	-282.98%	-206.38%	-96.07%	-1285.20%
Profit Margin	-320.91%	-2901.15%	-282.98%	-206.38%	-106.42%	-1285.20%
FCF Margin	-205.12%	-2177.08%	-438.64%	-351.07%	-51.03%	-1369.57%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 26, 2026	Nov '25 Nov 30, 2025	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021
PS Ratio	10.44	93.41	16.33	13.05	14.39	87.04